Howard Hughes Medical Institute’s Eaton ETN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-84
Closed -$26.8K 191
2025
Q4
$26.8K Hold
84
0.02% 87
2025
Q3
$31.4K Sell
84
-1
-1% -$364 0.02% 75
2025
Q2
$30.3K Buy
+85
New +$26.2K 0.01% 71
2017
Q2
Sell
-4,063
Closed -$301K 164
2017
Q1
$301K Buy
4,063
+3,729
+1,116% +$265K 0.06% 107
2016
Q4
$22K Buy
+334
New +$21.9K 0.01% 145
2016
Q1
Sell
-5,464
Closed -$284K 176
2015
Q4
$284K Buy
+5,464
New +$296K 0.04% 120
2015
Q3
Sell
-2,787
Closed -$188K 164
2015
Q2
$188K Sell
2,787
-133
-5% -$9.39K 0.04% 126
2015
Q1
$198K Buy
+2,920
New +$199K 0.03% 128

Other funds holding ETN

Howard Hughes Medical Institute's ETN Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Eaton (ETN) in Q1 2026, closing a stake of 84 shares — an estimated $26.8K sold.

Howard Hughes Medical Institute first reported a position in ETN in Q1 2015 and held it in 8 quarters. The position peaked at $301K in Q1 2017. 2,514 funds tracked by Wall St. Rank hold ETN as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Eaton position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 84 Eaton shares in Q1 2026, an estimated $26.8K.
  • Howard Hughes Medical Institute first reported a position in Eaton in Q1 2015 and held it in 8 quarters.
  • Howard Hughes Medical Institute's Eaton position peaked at $301K in Q1 2017.
  • 2,514 funds tracked by Wall St. Rank held Eaton as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.